NCT01844895View on ClinicalTrials.gov

Methotrexate-Inadequate Response Autoinjector Device Sub Study

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Abatacept

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY